Advertisement

Subcutaneous Panniculitis-Like T-Cell Lymphoma

  • Amrita Goyal
  • Joi B. Carter
  • Lyn McDivitt DuncanEmail author

Abstract

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a cytotoxic T-cell lymphoma with an excellent prognosis. Patients present with recurrent, generally painless, erythematous subcutaneous tumors on the trunk and extremities, often followed by lipoatrophy. Of note, this diagnosis previously encompassed two different diseases: lymphomas composed of alpha/beta-type T cells and lymphomas of gamma/delta T cells [1]. In the most recent WHO-EORTC guidelines, these have now been separated into SPTCL and primary cutaneous gamma/delta T-cell lymphoma (pcGDTCL), respectively [2]. Older studies, which lumped together both the alpha/beta and gamma/delta lymphomas, may report lower 5-year survival rates and poorer prognosis, reflecting the more aggressive course of pcGDTCL. This chapter discusses the clinical presentation, prognosis, and treatment of SPTCL, as well as its histopathology and immunohistochemistry. The chapter closes with a differential diagnosis and a clinical case.

Keywords

Subcutaneous panniculitis-like T-cell lymphoma SPTCL CD8+ cytotoxic T-cell lymphoma Alpha/beta TCR Hemophagocytic syndrome Primary cutaneous gamma-delta T-cell lymphoma Erythema nodosum Lupus profundus Lupus panniculitis 

References

  1. 1.
    Salhany K, Macon W. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol. 1998;22:881–93.PubMedCrossRefGoogle Scholar
  2. 2.
    Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111:838–45.PubMedCrossRefGoogle Scholar
  3. 3.
    Jaffe ES, Gaulard P, Ralfkiaer E, Cerroni L, Meijer CJLM. Subcutaneous panniculitis-like T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008. p. 294–5.Google Scholar
  4. 4.
    Kumar S, Krenacs L, Medeiros J, Elenitoba-Johnson KS, Greiner TC, Sorbara L, et al. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol. 1998;29:397–403.PubMedCrossRefGoogle Scholar
  5. 5.
    Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15:17–27.PubMedCrossRefGoogle Scholar
  6. 6.
    Wang HH, Myers T, Lach LJ, Hsieh CC, Kadin ME. Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis. Cancer. 1999;86:1240–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Parveen Z, Thompson K. Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas. Arch Pathol Lab Med. 2009;133:303–8.PubMedGoogle Scholar
  8. 8.
    Magro CM, Crowson A, Kovatich A, Burns F. Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia. J Cutan Pathol. 2001;28:235–47.PubMedCrossRefGoogle Scholar
  9. 9.
    Von den Driesch P, Staib G, Simon M, Sterry W. Subcutaneous T-cell lymphoma. J Am Acad Dermatol. 1997;36:285–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJLM, Müller-Hermelink HK, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003;97:610–27.PubMedCrossRefGoogle Scholar
  11. 11.
    Gaulard P, Berti E, Willemze R, Jaffe ES. Primary cutaneous peripheral T-cell lymphomas, rare subtypes. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008. p. 302–5.Google Scholar
  12. 12.
    Krenacs L, Smyth MJ, Bagdi E, Krenacs T, Kopper L, Rudiger T, et al. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. Blood. 2003;101:3590–3.PubMedCrossRefGoogle Scholar
  13. 13.
    Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol. 1998;37:667–72.PubMedCrossRefGoogle Scholar
  14. 14.
    Thurber S, Kohler S. Histopathologic spectrum of erythema nodosum. J Cutan Pathol. 2006;33:18–26.PubMedCrossRefGoogle Scholar
  15. 15.
    Pincus LB, LeBoit PE, McCalmont TH, Ricci R, Buzio C, Fox LP, et al. Subcutaneous panniculitis-like T-cell lymphoma with overlapping clinicopathologic features of lupus erythematosus: coexistence of 2 entities? Am J Dermatopathol. 2009;31:520–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Watanabe T, Tsuchida T. Lupus erythematosus profundus: a cutaneous marker for a distinct clinical subset? Br J Dermatol. 1996;134:123–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Martens P, Moder K, Ahmed I. Lupus panniculitis: clinical perspectives from a case series. J Rheumatol. 1999;26:68–72.PubMedGoogle Scholar
  18. 18.
    Facchetti F, Jones D, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008. p. 145–7.Google Scholar
  19. 19.
    Beaty MW, Toro J, Sorbara L, Stern JB, Pittaluga S, Raffeld M, et al. Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features. Am J Surg Pathol. 2001;25:1111–20.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Amrita Goyal
    • 1
  • Joi B. Carter
    • 2
  • Lyn McDivitt Duncan
    • 3
    Email author
  1. 1.Harvard-MIT Division of Health Sciences and TechnologyHarvard Medical SchoolBostonUSA
  2. 2.Department of DermatologyMassachusetts General Hospital, Harvard Medical SchoolBostonUSA
  3. 3.Dermatopathology Service, Department of PathologyMassachusetts General Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations